BRIEF-Immunotech Biopharm Says Jiaze Global Capital To Subscribe For New Convertible Bonds, Note

Reuters
Jan 20
BRIEF-Immunotech Biopharm Says Jiaze Global Capital To Subscribe For New Convertible Bonds, Note

Jan 20 (Reuters) - Immunotech Biopharm Ltd 6978.HK:

  • JIAZE GLOBAL CAPITAL TO SUBSCRIBE FOR NEW CONVERTIBLE BONDS AND NOTE

  • NEW CONVERTIBLE BONDS PRINCIPAL AMOUNT RMB270 MILLION

  • PRINCIPAL AMOUNT OF NOTES RMB30 MILLION

Further company coverage: 6978.HK

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10